John Wiley and Sons Ltd provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Prostate Cancer (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Prostate Cancer published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Oncologyrank 267 of 347 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Prostate Cancer
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Prostate Cancer is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access (listed in DOAJ); article processing charge listed at about US$1,000.
02Review time
Review time of Prostate Cancer
Each paper took a different time. The green box holds the middle half of the papers and the dark line is the median; the whiskers reach the fastest 10% and the slowest 10%. Plan with the whole spread, not only the median.
Half of the research articles Prostate Cancer published between Jan 2025 and Jan 2026 were accepted within 190 days of submission, and the middle half took between 130 and 280 days. This time includes peer review and any revision rounds. Papers that were rejected are not counted, because only published papers carry these dates.
In Oncology, Prostate Cancer ranks 112 of 125 journals by review time (1 = fastest). See the fastest-review journals in Oncology →
03Fee waivers
APC waivers and discounts for Prostate Cancer
Prostate Cancer follows the waiver policy of its publisher, Wiley: full waiver or 50% discount by Wiley's country list (close to Research4Life), applied automatically when enough of the authors are eligible. The corresponding author's country decides the group, and for a full waiver at least half of all authors must be affiliated in a country of the same eligible group.
Authors affiliated in 84 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Prostate Cancer is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Who funds research published in Prostate Cancer
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Prostate Cancer? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
04Indexing
Indexing of Prostate Cancer
- ISSN
- 2090-3111
- eISSN
- 2090-312X
- Publisher
- John Wiley and Sons Ltd
- Country
- United States
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Oncology
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
05Reviewer comments
Reviewer comments and rejection reasons for Prostate Cancer
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Prostate Cancer, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
06Journal Finder
Find the right journal for your paper
Is Prostate Cancer right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
07Questions
Frequently asked questions
How long is the review time of Prostate Cancer?
Based on 27 research articles Prostate Cancer published from Jan 2025 to Jan 2026, the median time from submission to acceptance was 190 days, and half of them were accepted between 130 and 280 days. After acceptance, papers appeared online after a median of 27 days. Source: received and accepted dates deposited by the publisher in Crossref, retrieved October 2026. Individual papers can take longer, especially with major revisions.
What is the impact factor of Prostate Cancer?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Prostate Cancer is 1.20: papers it published in the two previous years were cited 1.20 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Prostate Cancer?
The h-index of Prostate Cancer is 38 (OpenAlex, October 2026): 38 of its papers have each been cited at least 38 times. Its i10-index is 144.
What is the APC of Prostate Cancer?
OpenAlex lists an article processing charge (APC) of about US$1,000 for Prostate Cancer, an open access journal (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Prostate Cancer?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Prostate Cancer is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Prostate Cancer indexed in Scopus?
Yes. Prostate Cancer appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Prostate Cancer an SCIE journal?
Prostate Cancer is listed in ESCI of the Web of Science Core Collection, but not in SCIE, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Prostate Cancer in Journal Citation Reports (JCR)?
Yes. Prostate Cancer is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Does Prostate Cancer offer an APC waiver?
Prostate Cancer follows the policy of Wiley: full waiver or 50% discount by Wiley's country list (close to Research4Life), applied automatically when enough of the authors are eligible. The corresponding author's country decides the group, and for a full waiver at least half of all authors must be affiliated in a country of the same eligible group. Rules verified 27 October 2026; confirm on the publisher's page.
Who funds research published in Prostate Cancer?
41% of 27 recent research articles in Prostate Cancer name a funder in Crossref; the funders named most often are Taif University, Shiraz University of Medical Sciences, Pfizer Japan.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Langmuir
- Energy
- Journal of Colloid and Interface Science
- Astronomy and Astrophysics
- Frontiers in Psychology
- Remote Sensing
- Journal of Clinical Oncology
- Journal of Organometallic Chemistry
- Journal of Materials Science
- Angewandte Chemie - International Edition
- International Journal of Environmental Research and Public Health
- Journal of Hepatology
- Biophysical Journal
- Medicine
Browse all journals: indexing, impact factor and reviewer comments →